Theraclone In the News
media@theraclone-sciences.com
206.805.1600
Access recent media coverage of Theraclone via the links below.
Influenza matrix protein 2 extracellular domain (M2e)
SciBX, July 15, 2010
Rodent of the week: closing in on a universal flu vaccine
Los Angeles Times Blog, July 2, 2010
Theraclone makes a breakthrough on universal flu vax
FierceVaccines, June 30, 2010
Researchers find rare flu antibodies
Edmonton Journal, June 29, 2010
Study finds body's potential universal flu defense
Reuters, June 28, 2010
Seattle's Theraclone makes a 'first step' on long road to universal flu vaccine
Seattle Times, June 28, 2010
Seattle company of verge of universal flu vaccine
King5.com, June 28, 2010
Flu Vaccines Hit a Wall
Technology Review, October 13, 2009
Antibodies found that prevent HIV from causing severe AIDS
Los Angeles Times, September 4, 2009
Biotech-assisted antibody discovery may lead to AIDS vaccine
Fierce Biotech, September 4, 2009
Discovery Of New HIV Antibodies Opens Door To Effective AIDS Vaccine
Medical News Today, September 4, 2009
Study finds potential way to make an AIDS vaccine
Reuters, September 3, 2009
Powerful HIV-Blocking Antibodies Raise New Hopes for Vaccine
Bloomberg, September 3, 2009
Discoveries Brighten Search for AIDS Vaccine
HealthDay News, September 3, 2009
Antibodies 'may aid HIV jab hunt'
BBC News, September 3, 2009
A fluttering in the breeze
The Economist, September 3, 2009
Unique antibodies may be the key for AIDS vaccine
The Globe and Mail News, September 3, 2009
Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle's Theraclone
Xconomy.com, April 7, 2009
Biotech firm attracts $29 million in 2nd funding round
Seattle Times, March 17, 2007
$29 million gives biotech Spaltudaq funds to grow
Seattle Post-Intelligencer, March 17, 2007
New biotech Spaltudaq has different take on cancer fight
Seattle Post-Intelligencer, January 24, 2005
Startup targets tumor weapons
Seattle Times, January 24, 2005